Invitae appoints Robert Dickey as interim CFO

Invitae announced that Robert Dickey has been named its interim CFO, effective immediately. Christine Gorjanc, who had assumed the interim CFO role in June 2023, will transition back to her prior role as the Company’s Chair of the Audit Committee of the Board of Directors and member of the Compensation Committee of the Board of Directors, effective immediately. Gorjanc will work closely with Mr. Dickey and the executive leadership team to ensure a smooth transition. She will also continue to assist the Company with the search for its permanent CFO. Dickey is a finance executive with over 25 years experience as a CFO as well as other C-level and board positions at both private and publicly traded life sciences and medical device companies. Dickey is experienced in all stages of the corporate lifecycle, including start-up and fundraising, the IPO process, high growth and turnarounds as well as interactions with directors, shareholders and the investment community.